Lupin's Mandideep facility receives EIR from USFDA

This report comes after the recent inspection of the facility that took place from August 7 to August 11, 2023. The inspection concluded with the facility being classified as "No Action Indicated" (NAI).

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3vDkE1u
via